Details for New Drug Application (NDA): 207865
✉ Email this page to a colleague
The generic ingredient in EMEND is fosaprepitant dimeglumine. There are eleven drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the fosaprepitant dimeglumine profile page.
Summary for 207865
Tradename: | EMEND |
Applicant: | Msd Merck Co |
Ingredient: | aprepitant |
Patents: | 1 |
Suppliers and Packaging for NDA: 207865
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
EMEND | aprepitant | FOR SUSPENSION;ORAL | 207865 | NDA | Merck Sharp & Dohme LLC | 0006-3066 | 0006-3066-03 | 1 POUCH in 1 CARTON (0006-3066-03) / 1 POWDER, FOR SUSPENSION in 1 POUCH (0006-3066-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SUSPENSION;ORAL | Strength | 125MG/KIT | ||||
Approval Date: | Dec 17, 2015 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Sep 26, 2027 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | PREVENTION OF NAUSEA AND VOMITING ASSOCIATED WITH CHEMOTHERAPY (CINV) |
Expired US Patents for NDA 207865
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Msd Merck Co | EMEND | aprepitant | FOR SUSPENSION;ORAL | 207865-001 | Dec 17, 2015 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription